Jarmo Hietala
Professor of Psychiatry, MD, PhD
Department of Psychiatry; Clinical Medicine, University of Turku jahi@utu.fi |
Psychiatry; Clinical neuroscience; Neuroimaging
Specialist in Psychiatry; Adjunct professor of Pharmacology; Professor of Psychiatry
Etiology and treatment of psychotic disorders
Psychoses, Psychopharmacology
- Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis (2020)
- NPJ Schizophrenia
- Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety (2020)
- Neuropsychopharmacology
- Magia: Robust Automated Image Processing and Kinetic Modeling Toolbox for PET Neuroinformatics (2020)
- Frontiers in Neuroinformatics
- [18F]SPA-RQ/PET Study of NK1 receptors in the Whole Body of Guinea Pig and Rat (2019)
- Scientific Reports
- Aivokuvantaminen psykoosien diagnostiikassa ja hoidossa (2019)
- Duodecim
- A study on the association of psychiatric diagnoses and childhood adversities with suicide risk (2019)
- Nordic Journal of Psychiatry
- Body mass index trajectories in childhood and adolescence - Risk for non-affective psychosis (2019)
- Schizophrenia Research
- Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study (2019)
- Journal of Affective Disorders
- Childhood adversity predicts persistence of suicidal thoughts differently in females and males at clinical high-risk patients of psychosis. Results of the EPOS project (2019)
- Early Intervention in Psychiatry
- In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients with First-Episode Psychosis (2019)
- JAMA Psychiatry



